查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1422745

全球經皮冠狀動脈介入治療市場預測（~2032 年）

Percutaneous Coronary Intervention Market Research Report Forecast till 2032
出版日期: | 出版商: Market Research Future | 英文 180 Pages | 訂單完成後即時交付

價格

經皮冠狀動脈介入治療市場規模預計在預測期內複合年增長率為 8.86%。

在機械進步、心血管感染的流行和老年人口不斷增長的推動下，經皮冠狀動脈介入治療市場預計將出現強勁增長。

依地區劃分，北美在 2022 年所佔份額最大。 這一份額歸因於對微創手術的需求增加、心血管疾病盛行率增加以及不健康的生活習慣等因素造成的市場成長。 同時，亞太地區預計將在預測期內出現最大的成長。 收入水準的提高、心血管疾病盛行率的增加以及醫療基礎設施的改善等因素預計將推動市場的成長。

本報告調查了全球經皮冠狀動脈介入治療市場，提供了市場的定義和概述，分析了市場增長的各種影響因素、市場規模的趨勢和預測，並按細分市場和地區分析了市場。它總結了細分、競爭環境以及主要公司概況。

目錄

第 1 章執行摘要

第 2 章市場概述

第 3 章研究方法

第 4 章市場動態

  • 促進因素
  • 抑制因素
  • 機會

第 5 章市場影響因素分析

  • 價值鏈分析
  • 波特五力分析COVID-19 對市場的影響洞察:經皮冠狀動脈介入產品的技術進步

第 6 章全球經皮冠狀動脈介入治療市場:依產品類型

  • 冠狀動脈支架
  • 球囊導管
  • 冠狀動脈導絲
  • 引導導管
  • 導套
  • 診斷導管
  • 交叉導管
  • 充氣裝置
  • 指導系統
  • 週邊血栓清除系統
  • 栓塞保護系統
  • 配件

第 7 章全球經皮冠狀動脈介入治療市場:依血管通路劃分

  • 摘要
    • 橈動脈
    • 股動脈

第 8 章全球經皮冠狀動脈介入治療市場:依最終使用者劃分

  • 摘要
    • 醫院/診所
    • 門診手術中心
    • 其他

第 9 章全球經皮冠狀動脈介入治療市場:按地區

  • 摘要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第 10 章競爭態勢

  • 摘要
  • 競爭基準測試
  • 主要公司市佔率分析
  • 主要成長策略
  • 開發專案數量最多的公司
  • 主要發展分析
  • 主要發展與成長策略
  • 主要公司的財務狀況

第 11 章公司簡介

  • BOSTON SCIENTIFIC CORPORATION
  • ABBOTT
  • MEDTRONIC
  • COOK
  • MERIT MEDICAL SYSTEM
  • TERUMO CORPORATION
  • APT MEDICAL INC
  • BECTON, DICKINSON, AND COMPANY
  • B. BRAUN SE
  • CARDINAL HEALTH
  • MERIL LIFE SCIENCES PVT. LTD
  • PLS MINIMALLY INVASIVE INTERVENTIONAL MEDICAL CO., LTD
  • MICROPORT SCIENTIFIC CORPORATION
  • LEPU MEDICAL TECHNOLOGY CO., LTD

第 12 章附錄

Product Code: MRFR/MED/2288-CR

Percutaneous Coronary Intervention Market Research Report Forecast till 2030

Overview

The Percutaneous Coronary Intervention Market is anticipated to register a notable CAGR of 8.86% during the forecast period.

The percutaneous coronary intervention market is set for vigorous growth driven by mechanical progressions, expanding commonness of cardiovascular infections, and a rising maturing populace. With an emphasis on insignificantly obtrusive techniques and creative stent innovations, the market is ready to observe supported extension, offering worked on quiet results, and adding to the development of interventional cardiology.

The normal growth in the market can be ascribed to the rising predominance of heart sicknesses and expanding inclination for negligibly obtrusive methodology.

Throughout recent years, the quantity of death and handicaps brought about via cardiovascular infection has ceaselessly expanded all over the planet. The issue, which incorporates coronary illness and stroke, was answerable for 33% of the passings across the globe in 2019. For example, in 2019, the World Wellbeing Organization assessed that almost 17.9 million people passed on from cardiovascular illnesses, representing 32% of every worldwide casualty. Respiratory failures and strokes were liable for 85% of these fatalities. Unfortunate food, actual latency, cigarette use, and hazardous liquor utilization are the most major conduct risk factors for coronary illness and stroke.

Market Segmentation

The Percutaneous Coronary Intervention Market segmentation, based on product type, includes coronary stents, ballon catheters, coronary guidewires, guiding catheters, guiding sheaths, diagnostic catheters, crossing catheters, inflation device, guidance system, peripheral thrombectomy system, embolic protection system, and accessories.

The Percutaneous Coronary Intervention Market segmentation, based on vascular access, includes radial and femoral.

The Percutaneous Coronary Intervention Market segmentation, based on end user, includes hospitals & clinics, ambulatory surgical centers, and others.

Regional Insights

The North America percutaneous coronary intervention market accounted for the largest market share in 2022. North America is further divided into the US and Canada. North America held the largest market share due to the increase in demand for minimally invasive procedures, increasing prevalence of cardiovascular diseases, and unhealthy lifestyle habits propelling regional market growth over the forecast period.

Europe percutaneous coronary intervention market accounted for the second-largest market share due to unhealthy lifestyle habits, increasing geriatric population, and extensive R&D activities. Furthermore, the Germany percutaneous coronary intervention market is attributed to hold the largest market share.

The Asia-Pacific percutaneous coronary intervention market is expected to be the fastest growing from 2023 to 2032 due to rising income levels, an increase in the prevalence of cardiovascular diseases, and better healthcare infrastructure. Moreover, China percutaneous coronary intervention market accounted to hold the largest market share, and the India percutaneous coronary intervention market is projected to be the fastest growing market in the Asia-Pacific region.

Major Players

Key Companies in the Percutaneous Coronary Intervention market includes Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Medtronic (Ireland), Cook (US), APT Medical Inc (China), Merit Medical System (US), Becton, Dickinson, and Company (US), Braun SE (Germany), Cardinal Health (US), Meril Life Sciences Pvt. Ltd (India), PLS Minimally Invasive International Medical Co Ltd (China), and Lepu Medical Technology Co., Ltd (China).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
    • 3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
    • 3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.4 FORECASTING TECHNIQUES
  • 3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.5.1 BOTTOM-UP APPROACH
    • 3.5.2 TOP-DOWN APPROACH
  • 3.6 DATA TRIANGULATION
  • 3.7 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 RISING PREVALENCE OF HEART DISEASES
    • 4.2.2 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
  • 4.3 RESTRAINTS
    • 4.3.1 RISK OF INFECTION
    • 4.3.2 COMPLICATIONS DURING CARDIAC CATHETERIZATION
  • 4.4 OPPORTUNITIES
    • 4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON KEY PLAYERS
    • 5.3.3 IMPACT ON DEMAND AND SUPPLY
  • 5.4 INSIGHTS: TECHNOLOGICAL ADVANCEMENT FOR PERCUTANEOUS CORONARY INTERVENTION PRODUCTS

6 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
    • 6.1.1 CORONARY STENTS
    • 6.1.2 BALLON CATHETERS
    • 6.1.3 CORONARY GUIDEWIRES
    • 6.1.4 GUIDING CATHETERS
    • 6.1.5 GUIDING SHEATHS
    • 6.1.6 DIAGNOSTIC CATHETERS
    • 6.1.7 CROSSING CATHETERS
    • 6.1.8 INFLATION DEVICE
    • 6.1.9 GUIDANCE SYSTEM
    • 6.1.10 PERIPHERAL THROMBECTOMY SYSTEM
    • 6.1.11 EMBOLIC PROTECTION SYSTEM
    • 6.1.12 ACCESSORIES

7 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS

  • 7.1 OVERVIEW
    • 7.1.1 RADIAL
    • 7.1.2 FEMORAL

8 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER

  • 8.1 OVERVIEW
    • 8.1.1 HOSPITALS & CLINICS
    • 8.1.2 AMBULATORY SURGICAL CENTERS
    • 8.1.3 OTHERS

9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 UK
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 SWITZERLAND
    • 9.3.7 NETHERLAND
    • 9.3.8 BELGIUM
    • 9.3.9 POLAND
    • 9.3.10 REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 AUSTRALIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 SINGAPORE
    • 9.4.7 THAILAND
    • 9.4.8 VIETNAM
    • 9.4.9 REST OF ASIA-PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 AFRICA
    • 9.5.2 LATIN AMERICA
    • 9.5.3 MIDDLE EAST

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING
  • 10.3 MARKET SHARE ANALYSIS MAJOR PLAYER
    • 10.3.1 BOSTON SCIENTIFIC CORPORATION
    • 10.3.2 ABBOTT
    • 10.3.3 MEDTRONIC
    • 10.3.4 TERUMO CORPORATION
    • 10.3.5 MICROPORT SCIENTIFIC CORPORATION
  • 10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • 10.5 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • 10.6 KEY DEVELOPMENT ANALYSIS
  • 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.7.1 PRODUCT LAUNCH / PRODUCT APPROVAL
    • 10.7.2 AGREEMENT
  • 10.8 MAJOR PLAYERS FINANCIAL
    • 10.8.1 SALES (USD MILLION), 2022
    • 10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

  • 11.1 BOSTON SCIENTIFIC CORPORATION
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 ABBOTT
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 MEDTRONIC
    • 11.3.1 COMPANY OVERVIEWS
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 COOK
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 MERIT MEDICAL SYSTEM
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 KEY STRATEGIES
  • 11.6 TERUMO CORPORATION
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY DEVELOPMENTS
    • 11.6.6 KEY STRATEGIES
  • 11.7 APT MEDICAL INC
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 BECTON, DICKINSON, AND COMPANY
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 B. BRAUN SE
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 CARDINAL HEALTH
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES
  • 11.11 MERIL LIFE SCIENCES PVT. LTD
    • 11.11.1 COMPANY OVERVIEWS
    • 11.11.2 FINANCIAL OVERVIEW
    • 11.11.3 PRODUCTS OFFERED
    • 11.11.4 KEY DEVELOPMENTS
    • 11.11.5 KEY STRATEGIES
  • 11.12 PLS MINIMALLY INVASIVE INTERVENTIONAL MEDICAL CO., LTD
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 FINANCIAL OVERVIEW
    • 11.12.3 PRODUCTS OFFERED
    • 11.12.4 KEY DEVELOPMENTS
    • 11.12.5 KEY STRATEGIES
  • 11.13 MICROPORT SCIENTIFIC CORPORATION
    • 11.13.1 COMPANY OVERVIEW
    • 11.13.2 FINANCIAL OVERVIEW
    • 11.13.3 PRODUCTS OFFERED
    • 11.13.4 KEY DEVELOPMENTS
    • 11.13.5 KEY STRATEGIES
  • 11.14 LEPU MEDICAL TECHNOLOGY CO., LTD
    • 11.14.1 COMPANY OVERVIEW
    • 11.14.2 FINANCIAL OVERVIEW
    • 11.14.3 PRODUCTS OFFERED
    • 11.14.4 KEY DEVELOPMENTS
    • 11.14.5 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CORONARY STENTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CORONARY GUIDEWIRES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDING CATHETERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDING SHEATHS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR DIAGNOSTICS CATHETERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CROSSING CATHETERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR INFLATION DEVICE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDANCE SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR PERIPHERAL THROMBECTOMY SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR EMBOLIC PROTECTION SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR ACCESSORIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR RADIAL, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR FEMORAL, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 20 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 22 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 23 GLOBAL: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 24 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 25 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 26 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 27 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 28 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 29 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 30 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 31 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 32 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 33 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 34 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 35 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 36 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 37 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 38 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 39 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 40 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 41 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 42 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 43 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 44 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 45 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 46 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 47 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 48 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 49 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 50 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 51 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 52 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 53 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 54 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 55 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 56 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 57 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 58 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 59 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 60 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 61 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 62 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 63 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 64 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 65 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 66 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 67 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 68 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 69 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 70 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 71 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 72 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 73 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 74 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 75 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 76 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 77 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 78 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 79 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 80 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 81 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 82 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 83 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 84 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 85 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 86 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 87 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 88 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 89 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 90 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 91 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 92 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 93 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 94 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 95 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 96 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 97 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 98 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 99 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 100 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 101 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 102 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 103 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 104 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 105 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 106 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 107 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 108 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 109 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 110 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 111 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 112 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 113 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 114 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 115 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 116 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 117 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 118 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 119 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 120 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 121 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 122 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 123 REST OT THE WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 124 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 125 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 126 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 127 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 128 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 129 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 130 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 131 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 132 LATIN AMERICA : PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 133 LATIN AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 134 LATIN AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 135 LATIN AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 136 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 137 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 138 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 139 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 140 MAJOR PLAYERS IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • TABLE 141 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 142 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 143 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 144 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 145 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 146 MOST ACTIVE PLAYER IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • TABLE 147 PRODUCT LAUNCH / PRODUCT APPROVAL
  • TABLE 148 AGREEMENT
  • TABLE 149 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 150 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
  • TABLE 151 ABBOTT: PRODUCTS OFFERED
  • TABLE 152 ABBOTT: KEY DEVELOPMENTS
  • TABLE 153 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 154 MEDTRONIC: KEY DEVELOPMENTS
  • TABLE 155 COOK: PRODUCTS OFFERED
  • TABLE 156 MERIT MEDICAL SYSTEM: PRODUCTS OFFERED
  • TABLE 157 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 158 TERUMO CORPORATION: KEY DEVELOPMENTS
  • TABLE 159 APT MEDICAL INC: PRODUCTS OFFERED
  • TABLE 160 BECTON, DICKINSON, AND COMPANY: PRODUCTS OFFERED
  • TABLE 161 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 162 CARDINAL HEALTH: PRODUCTS OFFERED
  • TABLE 163 MERIL LIFE SCIENCES PVT. LTD: PRODUCTS OFFERED
  • TABLE 164 PLS MINIMALLY INVASIVE INTERNATIONAL MEDICAL CO LTD: PRODUCTS OFFERED
  • TABLE 165 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 166 MICROPORT SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
  • TABLE 167 LEPU MEDICAL TECHNOLOGY CO., LTD: PRODUCTS OFFERE

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET STRUCTURE
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS OF THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 10 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2022 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE, BY PRODUCT TYPE, 2022
  • FIGURE 12 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, VASCULAR ACCESS SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 13 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2022 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE, BY VASCULAR ACCESS, 2022 (USD MILLION)
  • FIGURE 15 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, END USER SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 16 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2022 & 2032 (USD MILLION)
  • FIGURE 17 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2022 (USD MILLION)
  • FIGURE 18 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2022 & 2032 (USD MILLION)
  • FIGURE 19 GLOBAL: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY REGION, 2022
  • FIGURE 20 NORTH AMERICA MARKET ANALYSIS: PERCUTANEOUS CORONARY INTERVENTION MARKET, 2019-2032 (USD MILLION)
  • FIGURE 21 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY,
  • FIGURE 22 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 23 EUROPE MARKET ANALYSIS: PERCUTANEOUS CORONARY INTERVENTION MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 25 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: PERCUTANEOUS CORONARY INTERVENTION MARKET, 2019-2030 (USD MILLION)
  • FIGURE 27 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
  • FIGURE 28 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 29 REST OF THE WORLD MARKET ANALYSIS: PERCUTANEOUS CORONARY INTERVENTION MARKET, 2019-2030 (USD MILLION)
  • FIGURE 30 REST OT THE WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2022 & 2030 (USD MILLION)
  • FIGURE 31 REST OT THE WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY REGION, 2022
  • FIGURE 32 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 33 MAJOR MANUFACTURER MARKET SHARE ANALYSIS, 2022
  • FIGURE 34 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKEPT
  • FIGURE 35 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 36 MAJOR PLAYERS SALES (USD MILLION), 2022
  • FIGURE 37 MAJOR PLAYER R&D EXPENDITURE (USD MILLION), 2022
  • FIGURE 38 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
  • FIGURE 40 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 ABBOTT: SWOT ANALYSIS
  • FIGURE 42 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 44 MERIT MEDICAL SYSTEM: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 45 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 46 APT MEDICAL INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 47 BECTON, DICKINSON, AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 48 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS
  • FIGURE 49 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 50 B. BRAUN SE: SWOT ANALYSIS
  • FIGURE 51 CARDINAL HEALTH.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 52 CARDINAL HEALTH: SWOT ANALYSIS
  • FIGURE 53 MICROPORT SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 54 LEPU MEDICAL TECHNOLOGY CO., LTD: FINANCIAL OVERVIEW SNAPSHOT